Charming Medical (MCTA) CFO submits initial insider ownership statement

Rhea-AI Filing Summary

Charming Medical Ltd filed an initial insider ownership report for its Chief Financial Officer, Cheung Ching Man

03/27/2026 - 07:03 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHEUNG CHING MAN

(Last) (First) (Middle)

UNITS 1803-1806, 18/F, HANG LUNG CENTRE

2-20 PATERSON STREET, CAUSEWAY BAY

(Street)

HONG KONG 00000

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Charming Medical Ltd [ MCTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ching Man Cheung	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Charming Medical (MCTA) disclose in this Form 3?

Charming Medical Ltd discloses an initial insider ownership report for its Chief Financial Officer, Cheung Ching Man. The filing identifies the officer role but shows no transactions or specific share amounts in the available data.

Who is the reporting person in Charming Medical (MCTA)'s Form 3?

The reporting person is Cheung Ching Man, who serves as Chief Financial Officer of Charming Medical Ltd. The filing confirms officer status but does not list any specific stock or derivative positions in the data provided.

Does Charming Medical (MCTA)'s Form 3 show any insider stock transactions?

No insider stock transactions are shown in this Form 3 data. The transaction summary reports zero buys, sells, exercises, gifts, tax withholdings, or restructurings, indicating a purely informational initial ownership filing.

Are any derivative securities reported in Charming Medical (MCTA)'s Form 3?

No derivative securities are reported in the available Form 3 data. The derivative summary is empty and derivativeTransactionCount is zero, indicating no options, warrants, or other derivative positions listed in this filing excerpt.

What is the net buy or sell direction in Charming Medical (MCTA)'s Form 3?

The net buy or sell direction is neutral in this Form 3. The transaction summary shows no buy or sell shares and a netBuySellDirection classified as neutral, reflecting the absence of reported trading activity.